Peter Attia

Oncology and Rare Disease Commercialization Intern @Mirador Global Llc

Los Angeles, CA, US
EMAILS
p•••••@miradorglobal.com
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Mar 2022 — Present

Oncology and Rare Disease Commercialization Intern @Mirador Global Llc

View department →

EDUCATION

2018 — 2024

Philadelphia College of Pharmacy

Doctor of Pharmacy - PharmD

2018 — 2022

University of the Sciences in Philadelphia

Pharmaceutical and Healthcare Studies

ABOUT PETER ATTIA

I am currently enrolled in my fourth professional year at the Philadelphia College of Pharmacy at the Saint Joseph\'s University pharmacy program and will graduate in May of 2024. During my first two years at the University of the Sciences, I took part in undergraduate-based research that studied relationships between social-communication skills, motor skills, and cognition in people on the autism spectrum. We use a range of scientific approaches in an effort to disentangle the complex web of skills that are needed for successful social interactions. After my two undergrad years, I joined a research study involving Merck and the Philadelphia College of Pharmacy. Our team researched and developed antibiotics before it became commercialized by Merck. The research study was based on the Stability of Imipenem/Cilastatin/Relebactam under different temperature and administration conditions and to determine the stability of imipenem/cilastatin/relebactam in polyvinyl chloride (PVC) infusion bags when stored at room temperature, refrigerated, frozen (in elastomeric infusion pumps) and in refrigerated continuous infusion devices. As a future PharmD, I am interested in pursuing a career in the industry and learning the different types of paths that I could take.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Peter Attia — Email, Phone Number & Contact Info | Unifers